{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:51:43Z","timestamp":1781614303747,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY027827"],"award-info":[{"award-number":["R01EY027827"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13346-025-01926-5","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T14:26:35Z","timestamp":1753712795000},"page":"1023-1034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sunitinib-eluting thin films for Inhibition of corneal neovascularization"],"prefix":"10.1007","volume":"16","author":[{"given":"Kunal S.","family":"Parikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagun","family":"Poudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3191-0771","authenticated-orcid":false,"given":"Qingguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"3","key":"1926_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 1998;43(3):245\u201369.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"1926_CR2","first-page":"182","volume":"8","author":"NS Abdelfattah","year":"2015","unstructured":"Abdelfattah NS, Amgad M, Zayed AA, et al. Clinical correlates of common corneal neovascular diseases: a literature review. Int J Ophthalmol. 2015;8(1):182\u201393.","journal-title":"Int J Ophthalmol"},{"issue":"6","key":"1926_CR3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/00003226-199511000-00014","volume":"14","author":"MR Dana","year":"1995","unstructured":"Dana MR, Schaumberg DA, Kowal VO, et al. Corneal neovascularization after penetrating keratoplasty. Cornea. 1995;14(6):604\u20139.","journal-title":"Cornea"},{"key":"1926_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/1735-1995.200266","volume":"22","author":"MN Hashemian","year":"2017","unstructured":"Hashemian MN, Mahrjerdi HZ, Mazloumi M, et al. Comparison of different doses of subconjunctival Sunitinib with bevacizumab in the treatment of corneal neovascularization in experimental rats. J Res Med Sci. 2017;22:16\u201316.","journal-title":"J Res Med Sci"},{"issue":"2","key":"1926_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1586\/eop.13.8","volume":"8","author":"ML Rolfsen","year":"2013","unstructured":"Rolfsen ML, Frisard NE, Stern EM, et al. Corneal neovascularization: a review of the molecular biology and current therapies. Expert Rev Ophthalmol. 2013;8(2):167\u201389.","journal-title":"Expert Rev Ophthalmol"},{"issue":"4","key":"1926_CR6","first-page":"242","volume":"12","author":"J-H Chang","year":"2001","unstructured":"Chang J-H, Gabison EE, Kato T, Azar DT. Corneal Neovascularization. 2001;12(4):242\u20139.","journal-title":"Corneal Neovascularization"},{"key":"1926_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40662-017-0094-6","volume":"4","author":"S Feizi","year":"2017","unstructured":"Feizi S, Azari AA, Safapour S. Therapeutic approaches for corneal neovascularization. Eye Vis (Lond). 2017;4:28\u201328.","journal-title":"Eye Vis (Lond)"},{"issue":"1","key":"1926_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/0974-9233.106384","volume":"20","author":"Q Xu","year":"2013","unstructured":"Xu Q, Kambhampati SP, Kannan RM. Nanotechnology approaches for ocular drug delivery. Middle East Afr J Ophthalmol. 2013;20(1):26\u201337.","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"4","key":"1926_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","volume":"16","author":"D Roshandel","year":"2018","unstructured":"Roshandel D, Eslani M, Baradaran-Rafii A, et al. Current and emerging therapies for corneal neovascularization. Ocul Surf. 2018;16(4):398\u2013414.","journal-title":"Ocul Surf"},{"issue":"2","key":"1926_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","volume":"134","author":"P Gain","year":"2016","unstructured":"Gain P, Jullienne R, He Z, et al. Global survey of corneal transplantation and eye banking. JAMA Ophthalmol. 2016;134(2):167\u201373.","journal-title":"JAMA Ophthalmol"},{"key":"1926_CR11","first-page":"12","volume":"185","author":"X Hu","year":"2014","unstructured":"Hu X, Liu S, Zhou G, Huang Y, Xie Z, Jing XJJ. Electrospinning Polym Nanofibers Drug Delivery Appl. 2014;185:12\u201321.","journal-title":"Electrospinning Polym Nanofibers Drug Delivery Appl"},{"key":"1926_CR12","doi-asserted-by":"crossref","unstructured":"Avgoustakis K. Polylactic-Co-Glycolic acid (PLGA). Encyclopedia of biomaterials and biomedical engineering. Editors: Wnek G., Bowlin G.; CRC; 2008. pp. 2259\u201369.","DOI":"10.1201\/b18990-216"},{"issue":"4","key":"1926_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1586\/erm.09.15","volume":"9","author":"J-M L\u00fc","year":"2009","unstructured":"L\u00fc J-M, Wang X, Marin-Muller C, et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn. 2009;9(4):325\u201341.","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"1926_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4155\/tde.14.91","volume":"6","author":"DN Kapoor","year":"2015","unstructured":"Kapoor DN, Bhatia A, Kaur R, Sharma R, Kaur G, Dhawan S. PLGA: a unique polymer for drug delivery. Therapeutic Delivery. 2015;6(1):41\u201358.","journal-title":"Therapeutic Delivery"},{"key":"1926_CR15","doi-asserted-by":"crossref","unstructured":"Rini BI, Sunitinib. Expert Opin Pharmacother. 2007;8(14):2359\u201369.","DOI":"10.1517\/14656566.8.14.2359"},{"issue":"3","key":"1926_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.oret.2016.10.007","volume":"1","author":"JE Knickelbein","year":"2017","unstructured":"Knickelbein JE, Jacobs-El N, Wong WT, et al. Systemic Sunitinib malate treatment for advanced juxtapapillary retinal hemangioblastomas associated with von Hippel-Lindau disease. Ophthalmol Retina. 2017;1(3):181\u20137.","journal-title":"Ophthalmol Retina"},{"key":"1926_CR17","doi-asserted-by":"crossref","unstructured":"Krishnan A, Forouharshad M, Heng E et al. Application of a degradable thin film to modulate perfusion to post-autotransplantation airways in rats. JTCVS Open 2025;24:510\u2013520.","DOI":"10.1016\/j.xjon.2025.01.008"},{"key":"1926_CR18","doi-asserted-by":"crossref","unstructured":"Parikh KS, Omiadze R, Josyula A et al. Ultra-thin, high strength, antibiotic-eluting sutures for prevention of ophthalmic infection. Bioeng Transl Med. 2021;6:e10204","DOI":"10.1002\/btm2.10204"},{"key":"1926_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jconrel.2022.11.020","volume":"353","author":"KS Parikh","year":"2023","unstructured":"Parikh KS, Josyula A, Inoue T, et al. Nanofiber-coated, tacrolimus-eluting sutures inhibit post-operative neointimal hyperplasia in rats. J Controlled Release. 2023;353:96\u2013104.","journal-title":"J Controlled Release"},{"issue":"3","key":"1926_CR20","doi-asserted-by":"publisher","first-page":"e10487","DOI":"10.1002\/btm2.10487","volume":"8","author":"A Josyula","year":"2023","unstructured":"Josyula A, Mozzer A, Szeto J, et al. Nanofiber-based glaucoma drainage implant improves surgical outcomes by modulating fibroblast behavior. Bioeng Translational Med. 2023;8(3):e10487.","journal-title":"Bioeng Translational Med"},{"issue":"1","key":"1926_CR21","doi-asserted-by":"publisher","first-page":"12911","DOI":"10.1038\/s41598-020-69687-4","volume":"10","author":"KS Parikh","year":"2020","unstructured":"Parikh KS, Josyula A, Omiadze R, et al. Nano-structured glaucoma drainage implant safely and significantly reduces intraocular pressure in rabbits via post-operative outflow modulation. Sci Rep. 2020;10(1):12911.","journal-title":"Sci Rep"},{"key":"1926_CR22","unstructured":"Parikh K, Patel H, Hanes J. Inventors. Process and apparatus for making aligned or twisted electrospun fibers and devices. US Patent 11,007,297. 2016."},{"issue":"6","key":"1926_CR23","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1167\/iovs.11-8499","volume":"53","author":"I-T Kim","year":"2012","unstructured":"Kim I-T, Park H-YL, Choi J-S, Joo C-K. Anti-angiogenic effect of KR-31831 on corneal and choroidal neovascularization in rat models. Invest Ophth Vis Sci. 2012;53(6):3111\u20139.","journal-title":"Invest Ophth Vis Sci"},{"key":"1926_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.nano.2019.01.001","volume":"17","author":"B Wang","year":"2019","unstructured":"Wang B, Tang Y, Oh Y, et al. Controlled release of dexamethasone sodium phosphate with biodegradable nanoparticles for preventing experimental corneal neovascularization. Nanomed Nanotechnol Biol Med. 2019;17:119\u201323.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"3","key":"1926_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jconrel.2010.10.023","volume":"149","author":"CG Park","year":"2011","unstructured":"Park CG, Kim E, Park M, Park J-H, Choy YB. A nanofibrous sheet-based system for linear delivery of Nifedipine. J Controlled Release. 2011;149(3):250\u20137.","journal-title":"J Controlled Release"},{"issue":"1","key":"1926_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/aic.690450116","volume":"45","author":"PW Gibson","year":"1999","unstructured":"Gibson PW, Schreuder-Gibson HL, Rivin D. Electrospun fiber mats: transport properties. AIChE J. 1999;45(1):190\u20135.","journal-title":"AIChE J"},{"issue":"2","key":"1926_CR27","first-page":"97","volume":"35","author":"H \u00c7akmak","year":"2016","unstructured":"\u00c7akmak H, Ergin K, Bozkurt G, Kocat\u00fcrk T, Evli\u00e7o\u011flu GE. The effects of topical everolimus and Sunitinib on corneal neovascularization. Cutan Ocul Toxicol. 2016;35(2):97\u2013103.","journal-title":"Cutan Ocul Toxicol"},{"key":"1926_CR28","doi-asserted-by":"crossref","unstructured":"Ko B-Y, Kim Y-s, Baek S-g et al. Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and Sunitinib in a rabbit model. Cornea. 2013;32(5):689\u201395.","DOI":"10.1097\/ICO.0b013e3182801645"},{"issue":"3","key":"1926_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12(3):348\u201360.","journal-title":"AAPS J"},{"key":"1926_CR30","doi-asserted-by":"publisher","first-page":"124699","DOI":"10.1016\/j.ijpharm.2024.124699","volume":"665","author":"S Taghe","year":"2024","unstructured":"Taghe S, Mirzaeei S, Pakdaman N, Kazemi A, Nokhodchi A. Macrolide-loaded nanofibrous inserts with Polycaprolactone and cellulose acetate base for sustained ocular delivery: Pharmacokinetic study in rabbit\u2019s eye. Int J Pharm. 2024;665:124699.","journal-title":"Int J Pharm"},{"issue":"1","key":"1926_CR31","doi-asserted-by":"publisher","first-page":"21806","DOI":"10.1038\/s41598-024-62026-x","volume":"14","author":"DR Kim","year":"2024","unstructured":"Kim DR, Park SK, Kim EJ, et al. Dexamethasone acetate loaded poly(\u03b5-caprolactone) nanofibers for rat corneal chemical burn treatment. Sci Rep. 2024;14(1):21806.","journal-title":"Sci Rep"},{"issue":"18","key":"1926_CR32","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1039\/D4BM00339J","volume":"12","author":"RA Alshaikh","year":"2024","unstructured":"Alshaikh RA, Chullipalliyalil K, Waeber C, Ryan KB. Extended Siponimod release via low-porosity PLGA fibres: a comprehensive three-month in vitro evaluation for neovascular ocular diseases. Biomater Sci. 2024;12(18):4823\u201344.","journal-title":"Biomater Sci"},{"issue":"9","key":"1926_CR33","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1007\/s13346-024-01527-8","volume":"14","author":"HE Teba","year":"2024","unstructured":"Teba HE, Khalil IA, Gebreel RM, Fahmy LI, Sorogy HME. Development of antifungal fibrous ocular insert using freeze-drying technique. Drug Delivery Translational Res. 2024;14(9):2520\u201338.","journal-title":"Drug Delivery Translational Res"},{"key":"1926_CR34","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/ICO.0b013e3182041755","volume":"30","author":"T Christopher","year":"2011","unstructured":"Christopher T, Hood M, Brian J, Lee M, Bennie H, Jeng M, Incidence. Occurrence rate, and characteristics of Suture-Related corneal infections after penetrating keratoplasty. Cornea. 2011;30:624\u20138.","journal-title":"Cornea"},{"issue":"Pt 1","key":"1926_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/eye.1995.18","volume":"9","author":"CJ Heaven","year":"1995","unstructured":"Heaven CJ, Davison CR, Cockcroft PM. Bacterial contamination of nylon corneal sutures. Eye (Lond). 1995;9(Pt 1):116\u20138.","journal-title":"Eye (Lond)"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01926-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01926-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01926-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:53:52Z","timestamp":1781610832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01926-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1926"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01926-5","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"15 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animals were cared for in accordance with protocols approved by the Johns Hopkins University Animal Care and Use Committee, the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and the National Institutes of Health guide for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}